Causality Assessment of Adverse Effects: When Is Re-Challenge Ethically Acceptable?

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.11, 2001-01, pp. : 793-799

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acceptable ICER for rufinamide in LGS?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 600, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Is Generic Prescribing Acceptable in Epilepsy?

By Besag F.M.C.

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 173-182

Adis International

Access to resources Recommend Favorite

Do Glucocorticoids Have Adverse Effects on Brain Function?

By Keenan P.A. Kuhn T.W.

CNS Drugs, Vol. 11, Iss. 4, 1999-04 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Research into rotavirus vaccine ethically justifiable?

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Can Decisional Algorithms Replace Global Introspection in the Individual Causality Assessment of Spontaneously Reported ADRs?

By Macedo Ana F. Marques Francisco B. Ribeiro Carlos F.

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 697-702

Adis International

Access to resources Recommend Favorite